BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34655610)

  • 1. Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling.
    Martins C; Migayron L; Drullion C; Jacquemin C; Lucchese F; Rambert J; Merhi R; Michon P; Taieb A; Rezvani HR; de Rinaldis E; Seneschal J; Boniface K
    J Invest Dermatol; 2022 Apr; 142(4):1194-1205.e7. PubMed ID: 34655610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
    Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
    Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
    Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
    PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocyte-keratinocyte cross-talk in vitiligo.
    Touni AA; Shivde RS; Echuri H; Abdel-Aziz RTA; Abdel-Wahab H; Kundu RV; Le Poole IC
    Front Med (Lausanne); 2023; 10():1176781. PubMed ID: 37275386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
    Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
    Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
    Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
    Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
    Wu J; Zhou M; Wan Y; Xu A
    Mol Med Rep; 2013 Jan; 7(1):237-41. PubMed ID: 23042234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
    Cario-André M; Pain C; Gauthier Y; Taïeb A
    Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken.
    Falcon DM; Byrne KA; Sales MA; Erf GF
    Front Immunol; 2024; 15():1386727. PubMed ID: 38720888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression.
    Rezk AF; Kemp DM; El-Domyati M; El-Din WH; Lee JB; Uitto J; Igoucheva O; Alexeev V
    J Invest Dermatol; 2017 May; 137(5):1126-1134. PubMed ID: 28132854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
    Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M
    Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment.
    Bzioueche H; Boniface K; Drullion C; Marchetti S; Chignon-Sicard B; Sormani L; Rocchi S; Seneschal J; Passeron T; Tulic MK
    Br J Dermatol; 2023 Aug; 189(3):312-327. PubMed ID: 37140010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
    Li YL; Yu CL; Yu HS
    J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.